CompletedNot Applicable

Immune Response in Dialysis Patients Vaccinated Against COVID-19

Russia52 participantsStarted 2021-03-23

Plain-language summary

This is a prospective cohort study aimed to evaluate short- and mid-term immune response after SARS-CoV-2 vaccination using Gam-COVID-Vac (Sputnik V) vaccine in dialysis patients compared to the control group (medical staff).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age of 18 years or older * Previously vaccinated against SARS-CoV-2 with two administrations of Gam-COVID-Vac (Sputnik V) vaccine * Written informed consent. Exclusion Criteria: * A history of previous COVID-19 disease * Active malignancy of any localization * Human Immunodeficiency Virus (HIV) infection * Maintenance treatment with immunosuppressive therapy.

What they're measuring

Humoral response to vaccination against against SARS-CoV-2 as compared to controls

Timeframe: 28 days after the second vaccination

Trial details

NCT IDNCT04805632

SponsorSaint Petersburg State University, Russia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-30

View on ClinicalTrials.gov More Covid19 trials